BIOMAT Database Logo BIOMAT Database Logo

[Use of trental and complamine in the microcirculatory disorders of diabetes mellitus]. 1980

V G Spesivtseva, and I N Kasabian, and G G Mamaeva, and V G Kukes

UI MeSH Term Description Entries
D007004 Hypoglycemic Agents Substances which lower blood glucose levels. Antidiabetic,Antidiabetic Agent,Antidiabetic Drug,Antidiabetics,Antihyperglycemic,Antihyperglycemic Agent,Hypoglycemic,Hypoglycemic Agent,Hypoglycemic Drug,Antidiabetic Agents,Antidiabetic Drugs,Antihyperglycemic Agents,Antihyperglycemics,Hypoglycemic Drugs,Hypoglycemic Effect,Hypoglycemic Effects,Hypoglycemics,Agent, Antidiabetic,Agent, Antihyperglycemic,Agent, Hypoglycemic,Agents, Antidiabetic,Agents, Antihyperglycemic,Agents, Hypoglycemic,Drug, Antidiabetic,Drug, Hypoglycemic,Drugs, Antidiabetic,Drugs, Hypoglycemic,Effect, Hypoglycemic,Effects, Hypoglycemic
D008297 Male Males
D008833 Microcirculation The circulation of the BLOOD through the MICROVASCULAR NETWORK. Microvascular Blood Flow,Microvascular Circulation,Blood Flow, Microvascular,Circulation, Microvascular,Flow, Microvascular Blood,Microvascular Blood Flows,Microvascular Circulations
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010431 Pentoxifylline A METHYLXANTHINE derivative that inhibits phosphodiesterase and affects blood rheology. It improves blood flow by increasing erythrocyte and leukocyte flexibility. It also inhibits platelet aggregation. Pentoxifylline modulates immunologic activity by stimulating cytokine production. Agapurin,BL-191,Oxpentifylline,Pentoxil,Torental,Trental,BL 191,BL191
D001769 Blood The body fluid that circulates in the vascular system (BLOOD VESSELS). Whole blood includes PLASMA and BLOOD CELLS.
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003925 Diabetic Angiopathies VASCULAR DISEASES that are associated with DIABETES MELLITUS. Diabetic Vascular Complications,Diabetic Vascular Diseases,Microangiopathy, Diabetic,Angiopathies, Diabetic,Angiopathy, Diabetic,Diabetic Angiopathy,Diabetic Microangiopathies,Diabetic Microangiopathy,Diabetic Vascular Complication,Diabetic Vascular Disease,Microangiopathies, Diabetic,Vascular Complication, Diabetic,Vascular Complications, Diabetic,Vascular Disease, Diabetic,Vascular Diseases, Diabetic
D003928 Diabetic Nephropathies KIDNEY injuries associated with diabetes mellitus and affecting KIDNEY GLOMERULUS; ARTERIOLES; KIDNEY TUBULES; and the interstitium. Clinical signs include persistent PROTEINURIA, from microalbuminuria progressing to ALBUMINURIA of greater than 300 mg/24 h, leading to reduced GLOMERULAR FILTRATION RATE and END-STAGE RENAL DISEASE. Diabetic Glomerulosclerosis,Glomerulosclerosis, Diabetic,Diabetic Kidney Disease,Diabetic Nephropathy,Intracapillary Glomerulosclerosis,Kimmelstiel-Wilson Disease,Kimmelstiel-Wilson Syndrome,Nodular Glomerulosclerosis,Diabetic Kidney Diseases,Glomerulosclerosis, Nodular,Kidney Disease, Diabetic,Kidney Diseases, Diabetic,Kimmelstiel Wilson Disease,Kimmelstiel Wilson Syndrome,Nephropathies, Diabetic,Nephropathy, Diabetic,Syndrome, Kimmelstiel-Wilson
D005260 Female Females

Related Publications

V G Spesivtseva, and I N Kasabian, and G G Mamaeva, and V G Kukes
[Trental treatment of microcirculatory disorders in diabetes mellitus and arteriosclerosis].
October 1982, Klinicheskaia meditsina,
V G Spesivtseva, and I N Kasabian, and G G Mamaeva, and V G Kukes
[Microcirculatory disorders in diabetes mellitus].
July 1982, Klinicheskaia meditsina,
V G Spesivtseva, and I N Kasabian, and G G Mamaeva, and V G Kukes
[Mechanism of the microcirculatory disorders in diabetes mellitus].
January 1983, Vestnik Akademii meditsinskikh nauk SSSR,
V G Spesivtseva, and I N Kasabian, and G G Mamaeva, and V G Kukes
[Microcirculatory disorders in hypertension, atherosclerosis, diabetes mellitus].
January 2011, Terapevticheskii arkhiv,
V G Spesivtseva, and I N Kasabian, and G G Mamaeva, and V G Kukes
[Comparative evaluation of the microcirculatory disorders in diabetes mellitus].
January 1982, Problemy endokrinologii,
V G Spesivtseva, and I N Kasabian, and G G Mamaeva, and V G Kukes
[Use of pentoxifylline (trental) to correct microcirculatory disorders in patients with atherosclerosis of peripheral arteries].
December 1986, Kardiologiia,
V G Spesivtseva, and I N Kasabian, and G G Mamaeva, and V G Kukes
[Blood viscosity and its role in microcirculatory disorders in diabetes mellitus].
January 1982, Terapevticheskii arkhiv,
V G Spesivtseva, and I N Kasabian, and G G Mamaeva, and V G Kukes
[Blood lipids, oxygen balance of tissues and microcirculatory disorders in diabetes mellitus].
January 1978, Terapevticheskii arkhiv,
V G Spesivtseva, and I N Kasabian, and G G Mamaeva, and V G Kukes
[Effect of trental on indices kidney function in diabetes mellitus].
January 1982, Problemy endokrinologii,
V G Spesivtseva, and I N Kasabian, and G G Mamaeva, and V G Kukes
[Use of teonikol and trental in the combined treatment of patients with suppurative surgical infection and concomitant diabetes mellitus].
December 1985, Klinicheskaia meditsina,
Copied contents to your clipboard!